Inovio Pharmaceuticals, Inc. (INO) has 20 known insider and institutional holders on record. The largest holder is Kim Jong Joseph with 139,386 shares. Other notable holders include Shea Jacqueline Elizabeth and Bagarazzi Mark.
Over the last 12 months, insiders have made 27 transactions in INO stock — 8 buys (valued at RSU Award) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
INO Insider Ownership
Top Holder
Kim Jong Joseph
139,386 shares
Buys (12 mo)
8
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Kim Jong Joseph |
Chief Executive Officer |
139,386 |
2022-03-14 |
|
| 2 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
78,760 |
2026-03-05 |
|
| 3 |
Bagarazzi Mark |
Chief Medical Officer |
55,133 |
2019-03-07 |
|
| 4 |
Sumner Michael John |
Chief Medical Officer |
29,608 |
2026-03-05 |
|
| 5 |
Kies Peter |
CFO |
25,520 |
2026-03-05 |
|
| 6 |
Sardesai Niranjan |
Chief Operating Officer |
25,000 |
2018-03-13 |
|
| 7 |
Humeau Laurent |
Chief Scientific Officer |
21,560 |
2026-03-05 |
|
| 8 |
Wysenski Nancy |
Director |
10,000 |
2016-05-16 |
|
| 9 |
Mahmoud Adel |
Director |
8,170 |
2018-05-14 |
|
| 10 |
Dhillon Avtar S |
Director |
8,170 |
2018-05-14 |
|
| 11 |
Collins Morton |
Director |
8,013 |
2019-05-09 |
|
| 12 |
Cabrera Angel |
Director |
8,013 |
2019-05-09 |
|
| 13 |
Bickerstaff George |
Director |
4,090 |
2018-03-22 |
|
| 14 |
Dansey Roger D |
Director |
2,167 |
2024-05-22 |
|
| 15 |
Yarno Wendy L |
Director |
2,167 |
2024-05-22 |
|
| 16 |
Benito Simon X |
Director |
2,167 |
2024-05-22 |
|
| 17 |
Shepard Jay |
Director |
2,167 |
2024-05-22 |
|
| 18 |
Miller Ann Calby |
Director |
2,167 |
2024-05-22 |
|
| 19 |
Zoth Lota S. |
Director |
2,167 |
2024-05-22 |
|
| 20 |
Weiner David B. |
Director |
2,167 |
2024-05-22 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-31 |
Sumner Michael John |
Chief Medical Officer |
Option Exercise (Sell) |
4,292 |
- |
- |
| 2026-03-04 |
Sumner Michael John |
Chief Medical Officer |
RSU Award |
29,608 |
- |
- |
| 2026-03-04 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
RSU Award |
78,760 |
- |
- |
| 2026-03-04 |
Humeau Laurent |
Chief Scientific Officer |
RSU Award |
21,560 |
- |
- |
| 2026-03-04 |
Kies Peter |
CFO |
RSU Award |
25,520 |
- |
- |
| 2026-02-26 |
Sumner Michael John |
Chief Medical Officer |
Option Exercise (Sell) |
5,010 |
- |
- |
| 2026-02-26 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
Option Exercise (Sell) |
18,632 |
- |
- |
| 2026-02-26 |
Humeau Laurent |
Chief Scientific Officer |
Option Exercise (Sell) |
5,010 |
- |
- |
| 2026-02-26 |
Weiner David B. |
Director |
Option Exercise (Sell) |
972 |
- |
- |
| 2026-02-26 |
Kies Peter |
CFO |
Option Exercise (Sell) |
5,010 |
- |
- |
| 2025-06-30 |
Sumner Michael John |
Chief Medical Officer |
Option Exercise (Sell) |
2,916 |
- |
- |
| 2025-05-20 |
Sumner Michael John |
Chief Medical Officer |
RSU Award |
28,350 |
- |
- |
| 2025-05-20 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
RSU Award |
84,888 |
- |
- |
| 2025-05-21 |
Miller Ann Calby |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
| 2025-05-20 |
Humeau Laurent |
Chief Scientific Officer |
RSU Award |
18,081 |
- |
- |
| 2025-05-21 |
Dansey Roger D |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
| 2025-05-21 |
Weiner David B. |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
| 2025-05-21 |
Shepard Jay |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
| 2025-05-21 |
Zoth Lota S. |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
| 2025-05-21 |
Benito Simon X |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
| 2025-05-20 |
Kies Peter |
CFO |
RSU Award |
26,100 |
- |
- |
| 2025-05-21 |
Yarno Wendy L |
Director |
Option Exercise (Sell) |
2,167 |
- |
- |
| 2025-05-15 |
Sumner Michael John |
Chief Medical Officer |
Option Exercise (Sell) |
2,385 |
- |
- |
| 2025-05-15 |
Shea Jacqueline Elizabeth |
Chief Executive Officer |
Option Exercise (Sell) |
17,744 |
- |
- |
| 2025-05-15 |
Humeau Laurent |
Chief Scientific Officer |
Option Exercise (Sell) |
4,771 |
- |
- |
